$LQDA news
The latest LQDA stock news: headlines, filings, AI summaries and sentiment for $LQDA, updated around the clock.
- Liquidia Corporation Upgraded to Strong Buy by Raymond James
- Liquidia Corporation Shares Rise 7% Following Q3 Results and Litigation Settlement
- Liquidia Reports Q3 2026 Growth Driven by YUTREPIA Sales and Legal Settlement
- Liquidia Announces Long-Term Clinical Timelines for PH-ILD and L606 NDA Submission
- Liquidia Corp - 8-K Filing
- Liquidia Corp - 10-Q Filing
- Liquidia Reports Q3 Revenue Beat Amid Significant Net Loss from Litigation Settlement
- Liquidia Shares Rise Nearly 27% Following Settlement with United Therapeutics
- Liquidia Reaches Settlement With United Therapeutics; Stock Rises Over 30%
- Liquidia Corp - 8-K Filing
- Biggest Stock Movers Include DELL, LQDA, and ENVX
- Liquidia Shares Rise Over 42% Following Settlement with United Therapeutics
- Wells Fargo Downgrades Liquidia Following Legal Setback
- Stocks Making Significant Moves Midday: Accenture, Synopsys, United Therapeutics, Vicor Among Others
- BTIG Downgrades Liquidia Stock to Neutral Amid Legal Setback
- Liquidia Corp - 8-K Filing
- Liquidia Shares Drop Over 57% Following Patent Litigation Ruling
- Stocks Making Significant Moves Midday: Rogers Surges on Earnings Guidance; United Therapeutics and Moderna See Sharp Movements
- Liquidia Shares Drop Sharply After Court Ruling in Patent Dispute with United Therapeutics
- Liquidia Corp - 8-K Filing
- Liquidia Reports Strong Q2 Earnings Driven by YUTREPIA Sales Growth
- Liquidia Rises as Judge Criticizes United Therapeutics in Patent Dispute
- Liquidia Corp - 8-K Filing
- Liquidia Reports Strong First Quarter Earnings for Q1 2026
- JW Asset Management Sells $3 Million Worth of Liquidia Shares Despite Stock's 175% Surge
- Liquidia CEO Sells 53,300 Shares for $2.1 Million via Indirect Vehicle
- Liquidia CEO Sells 53,300 Shares Indirectly for $2.1 Million